615 related articles for article (PubMed ID: 29223834)
41. Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.
Casteillo F; Guy JB; Dal-Col P; Karpathiou G; Pommier B; Bayle-Bleuez S; Fournel P; Vassal F; Forest F
Am J Surg Pathol; 2018 Dec; 42(12):1701-1707. PubMed ID: 30222604
[TBL] [Abstract][Full Text] [Related]
42. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
[TBL] [Abstract][Full Text] [Related]
43. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.
Ujiie H; Kadota K; Chaft JE; Buitrago D; Sima CS; Lee MC; Huang J; Travis WD; Rizk NP; Rudin CM; Jones DR; Adusumilli PS
J Clin Oncol; 2015 Sep; 33(26):2877-84. PubMed ID: 26261257
[TBL] [Abstract][Full Text] [Related]
44. Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less: impact on recurrence and clinical predictors.
Yoshida Y; Nitadori JI; Shinozaki-Ushiku A; Sato J; Miyaji T; Yamaguchi T; Fukayama M; Nakajima J
Gen Thorac Cardiovasc Surg; 2017 May; 65(5):273-279. PubMed ID: 28243892
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis.
Xu C; Zhu K; Chen D; Ruan Y; Jin Z; Qiu H; Chen B; Shen J
Front Surg; 2021; 8():795921. PubMed ID: 34993229
[No Abstract] [Full Text] [Related]
46. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
[TBL] [Abstract][Full Text] [Related]
47. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
[TBL] [Abstract][Full Text] [Related]
48. Discohesive growth pattern (Disco-p) as an unfavorable prognostic factor in lung adenocarcinoma: an analysis of 1062 Japanese patients with resected lung adenocarcinoma.
Rokutan-Kurata M; Yoshizawa A; Nakajima N; Teramoto Y; Sumiyoshi S; Kondo K; Hamaji M; Sonobe M; Menju T; Date H; Haga H
Mod Pathol; 2020 Sep; 33(9):1722-1731. PubMed ID: 32313186
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
Kim M; Chung YS; Kim KA; Shim HS
Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
[TBL] [Abstract][Full Text] [Related]
50. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
[TBL] [Abstract][Full Text] [Related]
52. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
Wang Y; Song W; Wang X; Che G
Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
[TBL] [Abstract][Full Text] [Related]
53. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H; Goo JM; Suh YJ; Park CM; Kim YT
Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
[TBL] [Abstract][Full Text] [Related]
54. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
55. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
[TBL] [Abstract][Full Text] [Related]
56. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.
Cao S; Teng J; Xu J; Han B; Zhong H
Thorac Cancer; 2019 Feb; 10(2):249-255. PubMed ID: 30561142
[TBL] [Abstract][Full Text] [Related]
57. Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.
Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
[TBL] [Abstract][Full Text] [Related]
58. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
59. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
